NASDAQ:SRZN Surrozen (SRZN) Stock Price, News & Analysis $28.46 -2.21 (-7.21%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$28.46 -0.01 (-0.02%) As of 11/20/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Surrozen Stock (NASDAQ:SRZN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Surrozen alerts:Sign Up Key Stats Today's Range$28.25▼$30.3450-Day Range$16.16▼$33.6852-Week Range$12.79▼$37.83Volume148,849 shsAverage Volume280,469 shsMarket Capitalization$542.50 millionP/E RatioN/ADividend YieldN/APrice Target$61.75Consensus RatingModerate Buy Company Overview Surrozen, Inc. is a biotechnology company developing antibody-based medicines designed to activate the Wnt signaling pathway, which plays a role in tissue growth and repair. The company uses its proprietary platform to develop therapies intended to stimulate regeneration in specific tissues while limiting effects elsewhere in the body. Surrozen’s research has included candidates aimed at liver disease and inflammatory bowel disease, including SZN-043 and SZN-1326. Its work focuses on advancing potential treatments through research and clinical development; the company’s products are investigational and are not approved medicines. Founded in 2016, Surrozen is based in South San Francisco, California. Its programs and platform reflect a focus on applying antibody engineering to regenerative medicine.AI Generated. May Contain Errors. Read More Surrozen Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreSRZN MarketRank™: 2.19276094276 of 5 starsSurrozen scored higher than 44% of companies evaluated by MarketBeat, and ranked 567th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingModerate Buy Consensus RatingSurrozen has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialSurrozen has a consensus price target of $61.75, representing about 117.0% upside from its current price of $28.46.Amount of Analyst CoverageSurrozen has only been the subject of 4 research reports in the past 90 days.Read more about Surrozen's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Surrozen are expected to grow in the coming year, from ($6.85) to ($4.71) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surrozen is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surrozen is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted40.82% of the float of Surrozen has been sold short.Short Interest Ratio / Days to CoverSurrozen has a short interest ratio ("days to cover") of 8.51.Change versus previous monthShort interest in Surrozen has recently increased by 3.31%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSurrozen does not currently pay a dividend.Dividend GrowthSurrozen does not have a long track record of dividend growth. News and Social Media1.3 / 5News Sentiment0.09 News SentimentSurrozen has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Surrozen this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for SRZN on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Surrozen insiders have not sold or bought any company stock.Percentage Held by Insiders31.74% of the stock of Surrozen is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions66.57% of the stock of Surrozen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Surrozen's insider trading history. Receive SRZN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surrozen and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SRZN Stock News HeadlinesGuggenheim Names Top Biotech Stock Pick Following JNJ Latest DealNovember 17, 2026 | uk.finance.yahoo.comHC Wainwright Comments on Surrozen FY2026 EarningsNovember 14, 2026 | americanbankingnews.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 22 at 1:00 AM | Porter & Company (Ad)Surrozen (NASDAQ:SRZN) Stock Rating Lowered by Wall Street ZenNovember 14, 2026 | americanbankingnews.comSurrozen Prices $60 Million OfferingNovember 13, 2026 | marketscreener.comMSurrozen Announces Pricing of $60 Million Underwritten Offering of Common StockNovember 13, 2026 | globenewswire.comCantor Fitzgerald Forecasts Strong Price Appreciation for Surrozen (NASDAQ:SRZN) StockNovember 12, 2026 | americanbankingnews.comSurrozen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 10, 2026 | marketscreener.comMSee More Headlines SRZN Stock Analysis - Frequently Asked Questions How have SRZN shares performed this year? Surrozen's stock was trading at $22.60 at the beginning of 2026. Since then, SRZN stock has increased by 25.9% and is now trading at $28.46. How were Surrozen's earnings last quarter? Surrozen, Inc. (NASDAQ:SRZN) released its earnings results on Monday, November, 9th. The company reported ($11.02) EPS for the quarter, missing the consensus estimate of ($1.10) by $9.92. When did Surrozen's stock split? Surrozen's stock reverse split before market open on Thursday, December 14th 2023.The 1-15 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. Who are Surrozen's major shareholders? Top institutional investors of Surrozen include Integral Health Asset Management LLC (2.80%), State Street Corp (1.17%), Regents of The University of California (1.15%) and Goldman Sachs Group Inc. (0.97%). Insiders that own company stock include Group Gp Lp Column III, Tim Kutzkey, Tcg Crossover Gp Ii, Llc, Yang Li, Charles O Williams and Craig C Parker. View institutional ownership trends. How do I buy shares of Surrozen? Shares of SRZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/09/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 SRZN's financial health is in the Green zone, according to TradeSmith. SRZN has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:SRZN CIK1824893 Webwww.surrozen.com Phone650-489-9000FaxN/AEmployees44Year Founded2016Price Target and Rating Average Price Target for Surrozen$61.75 High Price Target$80.00 Low Price Target$51.00 Potential Upside/Downside+117.0%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($43.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$242.03 million Net Margins-2,885.33% Pretax Margin-3,706.41% Return on EquityN/A Return on Assets-112.96% Debt Debt-to-Equity RatioN/A Current Ratio7.56 Quick Ratio7.56 Sales & Book Value Annual Sales$10.53 million Price / Sales51.53 Cash FlowN/A Price / Cash FlowN/A Book Value($17.61) per share Price / Book-1.62Miscellaneous Outstanding Shares19,062,000Free Float13,012,000Market Cap$542.50 million OptionableOptionable Beta0.51 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:SRZN) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredA quick test most investors failCan you defend your biggest holding? Seeking Alpha Premium gives you its Quant valuation grade versus its sect...Seeking Alpha | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.